• Explore /
  • Poster
  • / Resectability, conversion and resections rates, and outcomes in <em>RAS</em>&<em>BRAF</em> wildtype (wt), <em>RAS</em> mutant (mt) and <em>BRAF</em>mt metastatic colorectal cancer (mCRC) subgroups in the prospective Finnish RAXO-study.

Resectability, conversion and resections rates, and outcomes in RAS&BRAF wildtype (wt), RAS mutant (mt) and BRAFmt metastatic colorectal cancer (mCRC) subgroups in the prospective Finnish RAXO-study.

Abstract Video & Slides Poster

Authors

Pia Osterlund

Pia J. Osterlund

Tampere University Hospital and University of Tampere, Department of Oncology, Tampere, Finland

Pia J. Osterlund , Emerik Osterlund , Aki Uutela , Päivi Halonen , Raija S. Kallio , Annika Ålgars , Tapio Salminen , Annamarja Lamminmäki , Leena-Maija Soveri , Raija Ristamäki , Kaisa I Lehtomäki , Hanna Stedt , Eetu Heervä , Arno Nordin , Ali Ovissi , Jari Sundström , Lasse Nieminen , Markus J Mäkinen , Ari Ristimäki , Helena Isoniemi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Epidemiology/Outcomes

Clinical Trial Registration Number

NCT01531621

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 3532)

DOI

10.1200/JCO.2021.39.15_suppl.3532

Abstract #

3532

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Romain Cohen

First Author: Kathryn Hitchcock

First Author: Miriam Koopman

First Author: Javier Soto Sr.